SEPTInvestingStart Free

VNRX 10-Q: SEC filing

VolitionRx

Filed with the SEC on · accession 0001477932-26-006881

VNRX filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. VolitionRx filed its Q3 2026 Form 10-Q, reporting routine quarterly financial results and disclosures including ATM sales, equity grants, and subsequent events. The stock moved -9.4% by the first close after the filing.

Summary of the filing

VolitionRx filed its Q3 2026 Form 10-Q, reporting routine quarterly financial results and disclosures including ATM sales, equity grants, and subsequent events. No single major corporate event dominates the filing.

For details, click here →How to read a 10-Q →

Key details

FilerVolitionRx Ltd
Collaboration/agreement counterpartyXenetic Biosciences Inc
Collaboration/agreement counterpartyCLS Therapeutics
LenderWallonie Entreprendre
LenderSANamur Invest Preface
ExecutiveCameron Reynolds
ExecutiveTimothy Still

How VNRX stock reacted

Close before

$0.20

Nov 11, 2026

First close after

-9.38%

$0.18

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for VNRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VNRX?

Click here

Frequently asked questions

What did VNRX file with the SEC on Nov 12, 2026?

VNRX filed a 10-Q (SEC filing). VolitionRx filed its Q3 2026 Form 10-Q, reporting routine quarterly financial results and disclosures including ATM sales, equity grants, and subsequent events. No single major corporate event dominates the filing.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did VNRX stock react to this filing?

VNRX closed at $0.20 before the filing and $0.18 on Nov 12, 2026 (-9.38%).

Other VNRX SEC filings

Get alerts when VNRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
VNRX overviewVNRX analysisVNRX newsLatest SEC filings